Back

Evaluation of prescribing with NOACs and VKAs in nonvalvular AF.

27 August 2016 (16:15 - 16:25)
Organised by:
Congress Presentation Part of: Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry Atrial fibrillation (AF) Open Access ESC Congress 2016

About the speaker

Photo
Professor Sylvia Haas

Technical University of Munich, Munich (Germany)

7 More presentations in this session

Presentation thumbnail
Global status of GARFIELD-AF.
Professor A. Kakkar (London, GB)
Slides Video
Presentation thumbnail
Treating low-risk patients with nonvalvular AF.
Professor J. Camm (London, GB)
Slides Video
Presentation thumbnail
Risk scores for patients with nonvalvular AF.
Professor K. Fox (Edinburgh, GB)
Slides Video
Presentation thumbnail
Characteristics of patients with nonvalvular AF receiving antiplatelet therapy.
Professor F. Verheugt (Amsterdam, NL)
Slides Video
Presentation thumbnail
Early mortality in newly diagnosed nonvalvular AF.
Doctor S. Goldhaber (Boston, US)
Slides Video

Access the full session

Session thumbnail
Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry

The Event

Event poster

ESC Congress 2016

27 August 2016 16:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources